Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons
Tóm tắt
Plasmalogens are a specific type of glycerophospholipid found in especially high levels in neuronal membranes. Decreased blood and brain levels of docosahexaenoic acid (DHA) containing plasmalogens are associated with decreased cognition and neuromuscular function in humans. Administration of 1-O-alkyl-2-acylglycerol (AAG) plasmalogen precursors containing DHA at the sn-2 position dose-dependently increase blood DHA plasmalogens and are neuroprotective in animal models of neurodegeneration at doses between 10 and 50 mg/kg. We conducted an investigational clinical trial in 22 cognitively impaired persons to evaluate the effects of an escalating oral dosing regimen of DHA-AAG from 900 to 3,600 mg/day over a 4-month period on blood serum plasmalogen and non-plasmalogen phospholipids and oxidative stress biomarkers. Safety, tolerability and therapeutic effects on cognition and mobility were also evaluated. DHA plasmalogen levels increased with increasing dose and remained significantly elevated at all treatment doses and durations. DHA plasmalogen levels were positively associated with catalase activity and negatively associated with malondialdehyde (MDA) levels. DHA-AAG supplementation normalized catalase activity in persons with low baseline catalase activity, normalized MDA levels in persons with high baseline MDA levels, and normalized superoxide dismutase activity in persons with high baseline SOD activity. Cognition improved in nine participants, was unchanged in nine, and declined in four. Mobility improved in twelve, was unchanged in five and declined in four participants. Changes in cognition and mobility were statistically significant versus a random outcome. Baseline DHA-plasmalogen levels were not predictive of clinical response. DHA-AAG was well tolerated at all dosages and no adverse reactions were observed.
Từ khóa
Tài liệu tham khảo
2021, The Top 5 Most Feared Health Conditions in 2021
Beeri, 2021, Sarcopenia Is Associated with Incident Alzheimer's Dementia, M Ild Cognitive Impairment, and Cognitive Decline, J. Am. Geriatr. Soc., 69, 1826, 10.1111/jgs.17206
Dorninger, 2017, From Peroxisomal Disorders to Common Neurodegenerative Diseases - the Role of Ether Phospholipids in the Nervous System, FEBS Lett., 591, 2761, 10.1002/1873-3468.12788
Dorninger, 2017, Reduced Muscle Strength in Ether Lipid-Deficient Mice Is Accompanied by Altered Development and Function of the Neuromuscular Junction, J. Neurochem., 143, 569, 10.1111/jnc.14082
Farooqui, 2000, Glycerophospholipids in Brain: Their Metabolism, Incorporation into Membranes, Functions, and Involvement in Neurological Disorders, Chem. Phys. lipids, 106, 1, 10.1016/s0009-3084(00)00128-6
Fujino, 2018, Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized, Placebo-Controlled Trial in Japan, J. Alzheimers Dis. Park., 8, 10.4172/2161-0460.1000419
Fujino, 2017, Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, EBioMedicine, 17, 199, 10.1016/j.ebiom.2017.02.012
Galvin, 2015, The Quick Dementia Rating System (Qdrs): A Rapid Dementia Staging Tool, Alzheimer's & Dement. Diagn. Assess. & Dis. Monit., 1, 249, 10.1016/j.dadm.2015.03.003
Ginsberg, 1998, Membrane Instability, Plasmalogen Content, and Alzheimer's Disease, J. Neurochem., 70, 2533, 10.1046/j.1471-4159.1998.70062533.x
Ginsberg, 1995, Disease and Anatomic Specificity of Ethanolamine Plasmalogen Deficiency in Alzheimer's Disease Brain, Brain Res., 698, 223, 10.1016/0006-8993(95)00931-f
Glaser, 1994, Plasmenylethanolamine Facilitates Rapid Membrane Fusion: a Stopped-Flow Kinetic Investigation Correlating the Propensity of a Major Plasma Membrane Constituent to Adopt an HII Phase with its Ability to Promote Membrane Fusion, Biochemistry, 33, 5805, 10.1021/bi00185a019
Glaser, 1995, Rapid Plasmenylethanolamine-Selective Fusion of Membrane Bilayers Catalyzed by an Isoform of Glyceraldehyde-3-Phosphate Dehydrogenase: Discrimination between Glycolytic and Fusogenic Roles of Individual Isoforms, Biochemistry, 34, 12193, 10.1021/bi00038a013
Goodenowe, 2019, Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study, Brain Sci., 9, 10.3390/brainsci9040092
Goodenowe, 2007, Peripheral Ethanolamine Plasmalogen Deficiency: a Logical Causative Factor in Alzheimer's Disease and Dementia, J. lipid Res., 48, 2485, 10.1194/jlr.p700023-jlr200
Goodenowe, 2021, Breaking Alzheimer's - A 15 Year Crusade to Expose the Cause and Deliver the Cure
Guan, 1999, Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease, J. Neuropathology Exp. Neurology, 58, 740, 10.1097/00005072-199907000-00008
Gutteridge, 1984, Lipid Peroxidation Initiated by Superoxide-dependent Hydroxyl Radicals Using Complexed Iron and Hydrogen Peroxide, FEBS Lett., 172, 245, 10.1016/0014-5793(84)81134-5
Han, 2001, Plasmalogen Deficiency in Early Alzheimer's Disease Subjects and in Animal Models: Molecular Characterization Using Electrospray Ionization Mass Spectrometry, J. Neurochem., 77, 1168, 10.1046/j.1471-4159.2001.00332.x
Han, 2005, Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease, Car, 2, 65, 10.2174/1567205052772786
Hossain, 2022, Plasmalogens, the Vinyl Ether-Linked Glycerophospholipids, Enhance Learning and Memory by Regulating Brain-Derived Neurotrophic Factor, Front. Cell. Dev. Biol., 10, 828282, 10.3389/fcell.2022.828282
Kamper, 2009, Global Rating of Change Scales: a Review of Strengths and Weaknesses and Considerations for Design, J. Man. Manip. Ther., 17, 163, 10.1179/jmt.2009.17.3.163
Kassmann, 2007, Axonal Loss and Neuroinflammation Caused by Peroxisome-Deficient Oligodendrocytes, Nat. Genet., 39, 969, 10.1038/ng2070
Kling, 2020, Circulating Ethanolamine Plasmalogen Indices in Alzheimer's Disease: Relation to Diagnosis, Cognition, and CSF Tau, Alzheimer's & Dement., 16, 1234, 10.1002/alz.12110
Kokkaliari, 1992, Serum Catalase as the Protective Agent against Inactivation of Alpha 1-proteinase Inhibitor by Hydrogen Peroxide; Comparison between Normal and Rheumatoid Sera, Biochem. Int., 28, 219
Lim, 2020, Relationships between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease, Jad, 76, 303, 10.3233/jad-191304
Mankidy, 2010, Membrane Plasmalogen Composition and Cellular Cholesterol Regulation: a Structure Activity Study, Lipids Health Dis., 9, 62, 10.1186/1476-511x-9-62
McAllister, 2020, Modified 30-Second Sit-To-Stand Test: Reliability and Validity in Older Adults Unable to Complete Traditional Sit-To-Stand Testing, J. Geriatr. Phys. Ther., 43, 153, 10.1519/jpt.0000000000000227
Messias, 2018, Plasmalogen Lipids: Functional Mechanism and Their Involvement in Gastrointestinal Cancer, Lipids Health Dis., 17, 41, 10.1186/s12944-018-0685-9
Munn, 2003, Deficiency in Ethanolamine Plasmalogen Leads to Altered Cholesterol Transport, J. lipid Res., 44, 182, 10.1194/jlr.m200363-jlr200
Pacifico, 2020, Prevalence of Sarcopenia as a Comorbid Disease: A Systematic Review and Meta-Analysis, Exp. Gerontol., 131, 110801, 10.1016/j.exger.2019.110801
Rouser, 1968, Curvilinear Regression Course of Human Brain Lipid Composition Changes with Age, Lipids, 3, 284, 10.1007/bf02531202
Senanayake, 2019, Plasmalogen Deficiency and Neuropathology in Alzheimer's Disease: Causation or Coincidence?, Alzheimer's & Dementia Transl. Res. & Clin. Interventions, 5, 524, 10.1016/j.trci.2019.08.003
Sindelar, 1999, The Protective Role of Plasmalogens in Iron-Induced Lipid Peroxidation, Free Radic. Biol. Med., 26, 318, 10.1016/s0891-5849(98)00221-4
Stables, 2011, Old and New Generation Lipid Mediators in Acute Inflammation and Resolution, Prog. Lipid Res., 50, 35, 10.1016/j.plipres.2010.07.005
Stadelmann-Ingrand, 2001, Plasmalogen Degradation by Oxidative Stress: Production and Disappearance of Specific Fatty Aldehydes and Fatty α-hydroxyaldehydes, Free Radic. Biol. Med., 31, 1263, 10.1016/s0891-5849(01)00720-1
Sullivan-Gunn, 2013, Elevated Hydrogen Peroxide and Decreased Catalase and Glutathione Peroxidase Protection Are Associated with Aging Sarcopenia, BMC Geriatr., 13, 104, 10.1186/1471-2318-13-104
Wood, 2011, Plasmalogen Deficit: A New and Testable Hypothesis for the Etiology of Alzheimer’s Disease, Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets
Wood, 2011, Cellular Diamine Levels in Cancer Chemoprevention: Modulation by Ibuprofen and Membrane Plasmalogens, Lipids Health Dis., 10, 214, 10.1186/1476-511x-10-214
Wood, 2010, Circulating Plasmalogen Levels and Alzheimer Disease Assessment Scale-Cognitive Scores in Alzheimer Patients, jpn, 35, 59, 10.1503/jpn.090059
Wood, 2011, Oral Bioavailability of the Ether Lipid Plasmalogen Precursor, PPI-1011, in the Rabbit: a New Therapeutic Strategy for Alzheimer's Disease, Lipids Health Dis., 10, 227, 10.1186/1476-511x-10-227
Wood, 2011, Targeted Metabolomic Analyses of Cellular Models of Pelizaeus-Merzbacher Disease Reveal Plasmalogen and Myo-Inositol Solute Carrier Dysfunction, Lipids Health Dis., 10, 102, 10.1186/1476-511x-10-102
Yoo, 1999, The Activation of the Rat Copper/zinc Superoxide Dismutase Gene by Hydrogen Peroxide through the Hydrogen Peroxide-Responsive Element and by Paraquat and Heat Shock through the Same Heat Shock Element, J. Biol. Chem., 274, 23887, 10.1074/jbc.274.34.23887